Related Experiment Videos

[Bilateral Wilms' tumour. Results of treatment in 29 children]

Krystyna Sawicz-Birkowska1, Wojciech Apoznanski, Bozenna Dembowska-Bagińska

  • 1Katedra i Klinika Chirurgii i Urologii Dzieciecej, Akademia Medyczna, ul. Skłodowskiej-Curie 50/52, 50-369 Wrocław, Poland. sawicz@chir.dz.wroc.pl

Medycyna Wieku Rozwojowego
|February 14, 2004
PubMed

Insights

This study analyzed 29 children with bilateral Wilms

Area of Science:

  • Pediatric Oncology
  • Nephroblastoma Research

Context:

  • Retrospective analysis of 29 children diagnosed with bilateral Wilms' tumour.
  • Patients aged 4 months to 5 years, treated under the O1-92 PPGL Protocol in Poland.
  • Utilized preoperative chemotherapy regimens including ACT, Vincristine (VCR), and Doxorubicin (DOX).

Purpose:

  • To evaluate the outcomes of neoadjuvant chemotherapy and surgical interventions for bilateral Wilms' tumour.
  • To assess the feasibility of kidney-sparing surgery in this pediatric patient cohort.
  • To determine the event-free survival (EFS) rates in children with bilateral Wilms' tumour.

Summary:

  • 26 patients underwent surgery post-cytoreductive chemotherapy; 12 had nephrectomy, while 28 had successful kidney-sparing procedures.
  • 19 out of 29 patients (65.5%) survived, including one with residual nephroblastoma.
  • Kaplan-Meier analysis indicated an EFS of 58% at 67 months for the studied group.

Impact:

  • Demonstrates the effectiveness of neoadjuvant chemotherapy and tailored surgical approaches in managing bilateral Wilms' tumour.
  • Highlights the high success rate of kidney-sparing surgery, preserving renal function in pediatric patients.
  • Provides valuable data on long-term outcomes and survival rates for this rare presentation of Wilms' tumour.